Physician profile
Danqing Guo
NPI 1245330869
$703.09
in general payments reported to CMS, 2019-2025
19 companies · $87.02 in 2025
The $87.02 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $365 · 2020: $131 · 2022: $87.80 · 2023: $18.65 · 2024: $14.24 · 2025: $87.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $119.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $88.08 | 2019 | |
| Depuy Synthes Sales INC. | $87.47 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.97 | 2019-2024 | Relistor |
| Pacira Therapeutics, INC. | $55.99 | 2019-2020 | |
| Piramal Critical Care | $53.99 | 2020-2023 | |
| Scilex Pharmaceuticals INC. | $42.40 | 2019 | |
| Sanofi-Aventis U.S. LLC | $41.56 | 2019-2020 | |
| Ibsa Pharma INC. | $34.12 | 2022-2025 | Flector, Licart, Tirosint |
| Biodelivery Sciences International, INC. | $30.30 | 2019 | |
| Collegium Pharmaceutical, INC. | $27.44 | 2025 | Belbuca |
| Allergan, INC. | $26.26 | 2019-2020 | |
| Biogen, INC. | $24.67 | 2020 | |
| Tersera Therapeutics LLC | $24.02 | 2019 | |
| Nalu Medical, INC. | $22.79 | 2025 | Nalu Neurostimulation System |
| Tonix Medicines, INC. | $21.39 | 2025 | Tonmya |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $20.81 | 2019 | |
| Amneal Pharmaceuticals LLC | $16.58 | 2022 | |
| Electronic Waveform Lab, INC. | $15.77 | 2019 | |
| Abbvie INC. | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danqing Guo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.